리가켐바이오
Not investment advice · For research purposes only; not a solicitation or an offer of any financial product. Past statistics do not indicate future outcomes. Facts from filings and public sources; not investment advice. No valuation estimate, direction or trading levels are provided.
① Fact table
Values as filed · consolidated / separate basis per year · no interpretation
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | Unit |
|---|---|---|---|---|---|---|
| Revenue | KRW 32.2bn | KRW 33.4bn | KRW 34.1bn | KRW 125.9bn | KRW 141.6bn | KRW |
| Operating income | -KRW 27.7bn | -KRW 50.4bn | -KRW 80.8bn | -KRW 20.9bn | -KRW 106.5bn | KRW |
| Net income | -KRW 23.4bn | -KRW 45.1bn | -KRW 73.7bn | KRW 7.8bn | -KRW 91.6bn | KRW |
| Total equity | KRW 258.8bn | KRW 219.6bn | KRW 148.2bn | KRW 616.0bn | KRW 507.6bn | KRW |
| Total liabilities | KRW 34.5bn | KRW 32.9bn | KRW 41.3bn | KRW 122.4bn | KRW 160.7bn | KRW |
| 부채비율(자체 계산: 부채총계 ÷ 자본총계 × 100, 자본 0 이하면 비움, 같은 해 같은 기준)· in house | 13.32 | 15 | 27.85 | 19.87 | 31.66 | % |
| Statement basis | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated |
Show raw values
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | Unit |
|---|---|---|---|---|---|---|
| Revenue | 32,157,006,379 | 33,412,042,600 | 34,145,640,069 | 125,898,140,997 | 141,553,069,341 | KRW |
| Operating income | -27,706,660,419 | -50,375,099,038 | -80,822,342,649 | -20,913,487,724 | -106,485,862,116 | KRW |
| Net income | -23,391,227,602 | -45,091,793,579 | -73,703,570,475 | 7,800,099,578 | -91,552,141,111 | KRW |
| Total equity | 258,774,750,791 | 219,598,926,036 | 148,221,267,204 | 615,998,105,853 | 507,613,912,386 | KRW |
| Total liabilities | 34,458,706,029 | 32,931,523,513 | 41,280,911,655 | 122,384,802,337 | 160,694,609,940 | KRW |
| 부채비율(자체 계산: 부채총계 ÷ 자본총계 × 100, 자본 0 이하면 비움, 같은 해 같은 기준) | 13.32 | 15 | 27.85 | 19.87 | 31.66 | % |
Source: dart_fnltt · Computed in house · card as of 2026-10-13 · Filing date per year: not on the card (see the filing timeline below) · 'in house' marks items computed from the values above
② Profitability breakdown
Arithmetic on the fact table only · same year, same basis · '—' where a value is missing or the denominator is 0 or below · in each panel the bar height maps the span from the most negative to the largest positive value onto the panel height · no interpretation attached
Source: computed in house from the fact table · card as of 2026-10-13
③ My own calculation
A simple residual-income formula. You enter the assumptions; only the base equity is filled in from the filing. The result is computed from your assumptions and is not a figure this site publishes.
V = B₀ + (ROE − r) × B₀ ÷ (1 + r − ω)
Fill in all four boxes to compute. The site fills in nothing but the base equity.
Computed in this browser only; nothing you type is sent or stored.
- Base close 2026-10-13
- 65,500
- 80%
- 61,067.33 ~ 71,123.95
- 90%
- 59,458.60 ~ 73,565.49
- Ledger row
- f8cdff4b…
Source: fsc_stock_price · published 2026-10-14T11:05:08+09:00 · No direction implied
No day scored yet — no basis for a hit rate.
- 2026-10-02Filing title as filed주식등의대량보유상황보고서(약식) original ↗Source: dart_disclosure
- 2026-09-30Filing title as filed투자판단관련주요경영사항 (iADC 플랫폼 공동연구 및 기술도입 계약 체결) original ↗Source: dart_disclosure
- 2026-09-08Filing title as filed기업설명회(IR)개최 original ↗Source: dart_disclosure
- 2026-08-31Filing title as filed대규모기업집단현황공시[분기별공시(개별회사용)] original ↗Source: dart_disclosure
- 2026-08-14Filing title as filed반기보고서 (2026.06) original ↗Source: dart_disclosure
- 2026-08-14Filing title as filed지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항 original ↗Source: dart_disclosure
- 2026-08-07Filing title as filed투자판단관련주요경영사항 (LNCB74(B7H4-ADC) 단독 개발 및 기술이전 권리 확보) original ↗Source: dart_disclosure
- 2026-08-04Filing title as filed주식등의대량보유상황보고서(일반) original ↗Source: dart_disclosure
- 2026-08-04Filing title as filed임원ㆍ주요주주특정증권등소유상황보고서 original ↗Source: dart_disclosure
- 2026-08-04Filing title as filed주식등의대량보유상황보고서(일반) original ↗Source: dart_disclosure
- 2026-07-31Filing title as filed주식등의대량보유상황보고서(약식) original ↗Source: dart_disclosure
- 2026-07-24Filing title as filed증권발행결과(자율공시) original ↗Source: dart_disclosure
- 2026-07-24Filing title as filed증권발행결과(자율공시) original ↗Source: dart_disclosure
- 2026-07-24Filing title as filed임원ㆍ주요주주특정증권등소유상황보고서 original ↗Source: dart_disclosure
- 2026-07-24Filing title as filed주식등의대량보유상황보고서(일반) original ↗Source: dart_disclosure
- 2026-07-22Filing title as filed[기재정정]주요사항보고서(유상증자결정) original ↗Source: dart_disclosure
- 2026-07-22Filing title as filed[기재정정]주요사항보고서(전환사채권발행결정) original ↗Source: dart_disclosure
- 2026-07-16Filing title as filed[기재정정]주요사항보고서(전환사채권발행결정) original ↗Source: dart_disclosure
- 2026-07-16Filing title as filed[기재정정]주요사항보고서(유상증자결정) original ↗Source: dart_disclosure
- 2026-07-09Filing title as filed투자판단관련주요경영사항 (LCB97 관련 마일스톤 기술료 수령) original ↗Source: dart_disclosure
| Layer | Badge | n | Note |
|---|---|---|---|
| range | unknown | 0 | 80%·90% 범위의 전향 적중 기록(목표일 개장 전 박제 → 종가 공표 뒤 채점) |
| fair_value | 제공 안 함 | 0 | 판별력 미확인 — 싣지 않음 |
| direction | 제공 안 함 | 0 | 판별력 미확인 — 싣지 않음 |
| trade_levels | 제공 안 함 | 0 | 판별력 미확인 — 싣지 않음 |
| Valuation estimate | not provided | — | Not published: no demonstrated discriminative power |
| Direction (up or down) | not provided | — | Not published: no demonstrated discriminative power |
| Trading levels | not provided | — | Not published: no demonstrated discriminative power |
Why this?
Checking…